Written by
Share article:
Cranfield, UK, 25th April 2024 – Over $5.3 billion has been raised by medical imaging AI companies since 2015. Despite a year on year decrease in deal volumes since 2023, the shift to larger and later funding rounds has meant funding injected into the market remains high.
However, with only 5 deals recorded in 2024 so far, vendors within the market with diminishing funding runways may be apprehensive about raising additional funds in the near future. Explore the changing landscape by clicking the link below.
This report covers:
- The total VC funding, number of deals, and average size of deal since 2015.
- The type of investments and distribution of funding by region since 2015.
- The distribution of medical imaging AI companies by funding and rank.
- Summary of vendors that have crossed the $100m threshold in terms of capital raised.
- Summary of top five most funded companies in the Americas, EMEA, and Asia.
Related Research
AI in Medical Imaging Company and Product Database 2024
A database showcasing FDA, CE-Mark and NMPA-approved medical imaging AI products as well as the VC funding landscape for medical imaging AI companies and a dashboard to compare commercially available AI platforms. The database is published quarterly enabling you to keep up to date with regulatory approvals, funding and platform partnerships from your competitiors.
The database provides insight on:
- Which vendors and solutions have received regulatory approval to evaluate strategic opportunities for partnership or acquisition.
- How AI platform strategies are evolving and the availability of algorithms by platform vendor to assess prospective sales channel opportunities.
- Which vendors have received the most, or, recent funding, to help assess market conditions and the evolution of VC investment into the AI in medical imaging sector.
About The Author
Ellie joined Signify Research in 2023 as part of the Medical Imaging team. She holds a BSc in Biomedical Sciences from the University of Bath and an MSc in Clinical Drug Development from University College London.
About the AI in Healthcare Team
Signify Research’s AI in Medical Imaging service provides expert market intelligence and detailed insights for several of the leading AI and Imaging IT vendors. Combining primary data collection and in-depth discussions with industry stakeholders, our thorough research approach yields credible quantitative and qualitative analysis, helping our customers make critical business decisions with confidence. Furthermore, our commitment to seeking a plurality of perspectives across the markets we cover guarantees that our insights remain independent and balanced.
About Signify Research
Signify Research provides healthtech market intelligence powered by data that you can trust. We blend insights collected from in-depth interviews with technology vendors and healthcare professionals with sales data reported to us by leading vendors to provide a complete and balanced view of the market trends. Our coverage areas are Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences and Healthcare IT.
Clients worldwide rely on direct access to our expert Analysts for their opinions on the latest market trends and developments. Our market analysis reports and subscriptions provide data-driven insights that business leaders use to guide strategic decisions. We also offer custom research services for clients who need information that can’t be obtained from our off-the-shelf research products or who require market intelligence tailored to their specific needs.
More Information
To find out more:
E: enquiries@signifyresearch.net
T: +44 (0) 1234 986111
www.signifyresearch.net
